Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 64, Number 9, May 10, 2005
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karlawish, J.H.T.
Right arrow Articles by Kim, S. Y.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karlawish, J.H.T.
Right arrow Articles by Kim, S. Y.H.
Related Collections
Right arrow All Clinical trials
Right arrow Alzheimer's disease
NEUROLOGY 2005;64:1514-1519
© 2005 American Academy of Neurology

The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment

J.H.T. Karlawish, MD, D. J. Casarett, MD, B. D. James, M.Bioethics, S. X. Xie, PhD and S. Y.H. Kim, MD, PhD

From the Departments of Medicine (Drs. Karlawish, Casarett, and James) and Biostatistics and Epidemiology (Dr. Xie) and Division of Geriatrics (Drs. Karlawish, Casarett, and James), University of Pennsylvania, Philadelphia Veterans Affairs Medical Center (Dr. Casarett), Alzheimer’s Disease Center (Drs. Karlawish, James, and Xie), Center for Bioethics (Drs. Karlawish and Casarett), and Center for Clinical Epidemiology and Biostatistics (Drs. Karlawish and Xie), and Leonard Davis Institute for Health Economics (Drs. Karlawish and Casarett), Philadelphia, PA, and Department of Psychiatry and Bioethics Program and Program for Improving Healthcare Decisions (Dr. Kim), Ann Arbor, MI.

Address correspondence and reprint requests to DrT. Karlawish, Institute on Aging, 3615 Chestnut St., Philadelphia, PA 19104; e-mail: jasonkar{at}mail.med.upenn.edu

Objective: To examine the severity of impairments in the decision-making abilities (understanding, appreciation, reasoning, and choice) and competency to make a decision to use an Alzheimer disease (AD)-slowing medication in patients with AD and the relationships between these impairments, insight, and overall cognition.

Methods: Semistructured in-home interviews were conducted with 48 patients with very mild to moderate AD and 102 family caregivers of patients with mild to severe AD recruited from the Memory Disorders Clinic of an AD center. The interview measured performance on the decision-making abilities and three expert psychiatrists’ judgment of competency based on their independent review of the patient interviews.

Results: There was considerable variation in patients’ performance on the measures of decision-making abilities. Three expert raters found 19 of 48 (40%) of the subjects competent. Competent patients were more likely to show awareness of their symptoms, prognosis, and diagnosis. A sensitivity analysis suggests that a MMSE score is helpful in discriminating capacity from incapacity only when below 19 or above 23.

Conclusions: Persons with mild to moderate Alzheimer disease (AD) have notable impairments in their ability to make an AD treatment decision, especially persons with moderate AD and persons who lack awareness of symptoms, prognosis, or diagnosis.


Editorial, see page 1494

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the May 10 issue to find the title link for this article.

Supported by National Institute on Aging grants K01-AG00931 and P30-AG01024, a Paul Beeson Physician Faculty Scholars Award, and a Greenwall Faculty Scholar in Bioethics; by a Health Services Research Career Development Award from the Department of Veterans Affairs and a Paul Beeson Physician Faculty Scholars Award (D.J.C.); by National Institute of Mental Health grant K23-MH64172 (S.Y.H.K.); and National Institute on Aging grant P30-AG10124 (S.X.X.).

Received August 10, 2004. Accepted in final form January 20, 2005.


Related articles in Neurology:

May 10 Highlights

Neurology 2005 64: 1492-1493. [Full Text]  

Who can say yes (or no) to a physician—and how does the physician know they can?
Michael P. McQuillen and Pierre Tariot
Neurology 2005 64: 1494-1495. [Full Text]  



This article has been cited by other articles:


Home page
AJGPHome page
J. M. Lai, T. M. Gill, L. M. Cooney, E. H. Bradley, K. A. Hawkins, and J. H. Karlawish
Everyday Decision-Making Ability in Older Persons With Cognitive Impairment
Am J Geriatr Psychiatry, August 1, 2008; 16(8): 693 - 696.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. M. Lai, K. A. Hawkins, C. P. Gross, and J. H. Karlawish
Self-Reported Distress After Cognitive Testing in Patients With Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2008; 63(8): 855 - 859.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. S. Appelbaum
Assessment of Patients' Competence to Consent to Treatment
N. Engl. J. Med., November 1, 2007; 357(18): 1834 - 1840.
[Full Text] [PDF]


Home page
NeurologyHome page
O. Okonkwo, H. R. Griffith, K. Belue, S. Lanza, E. Y. Zamrini, L. E. Harrell, J. C. Brockington, D. Clark, R. Raman, and D. C. Marson
Medical decision-making capacity in patients with mild cognitive impairment
Neurology, October 9, 2007; 69(15): 1528 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. M. Halbekath, S. Schenk, A. von Maxen, G. Meyer, and I. Muhlhauser
Risedronate for the Prevention of Hip Fractures: Concern About Validity of Trials
Arch Intern Med, March 12, 2007; 167(5): 513 - 514.
[Full Text] [PDF]


Home page
AJGPHome page
J. M. Lai and J. Karlawish
Assessing the Capacity to Make Everyday Decisions: A Guide for Clinicians and an Agenda for Future Research
Am J Geriatr Psychiatry, February 1, 2007; 15(2): 101 - 111.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
S. Y.H. Kim, E. D. Caine, J. G. Swan, and P. S. Appelbaum
Do Clinicians Follow a Risk-Sensitive Model of Capacity-Determination? An Experimental Video Survey
Psychosomatics, August 1, 2006; 47(4): 325 - 329.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
K. B. Hirschman, J. M. Kapo, and J. H.T. Karlawish
Why Doesn't a Family Member of a Person With Advanced Dementia Use a Substituted Judgment When Making a Decision for That Person?
Am J Geriatr Psychiatry, August 1, 2006; 14(8): 659 - 667.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. Y H Kim
When Does Decisional Impairment Become Decisional Incompetence? Ethical and Methodological Issues in Capacity Research in Schizophrenia
Schizophr Bull, January 1, 2006; 32(1): 92 - 97.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Y.H. Kim, H. M. Kim, C. McCallum, and P. N. Tariot
What do people at risk for Alzheimer disease think about surrogate consent for research?
Neurology, November 8, 2005; 65(9): 1395 - 1401.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
K. B. Hirschman, C. M. Joyce, B. D. James, S. X. Xie, D. J. Casarett, and J. H.T. Karlawish
Would Caregivers of Alzheimer Disease Patients Involve Their Relative in a Decision to Use an AD-Slowing Medication?
Am J Geriatr Psychiatry, November 1, 2005; 13(11): 1014 - 1021.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. P. McQuillen and P. Tariot
Who can say yes (or no) to a physician--and how does the physician know they can?
Neurology, May 10, 2005; 64(9): 1494 - 1495.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.